Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • Challenge: Applying computer vision to medical imaging

Prostate cancer can take considerable time to progress to lethal disease and for some typical risk nomograms are inadequate predictors. Recent innovations in imaging such as mpMRI enrich for those at highest risk but do not resolve the challenges of predicting hard clinical endpoints such as lethality from the disease. Oxford researchers are identifying lethality features in PSA detected localised prostate cancer by interrogating archival ProtecT and ProMPT cohorts, and novel 3-D microscopy platforms link unique morphological features, genomic instability, and alterations in genomic loci that researchers have found to associate with poor prognosis disease in ICGC and other large-scale genomics studies.